Zobrazeno 1 - 10
of 62
pro vyhledávání: '"EPR, enhanced permeability and retention"'
Autor:
Fernando Novio
Publikováno v:
Molecules, Vol 25, Iss 15, p 3449 (2020)
Conventional cancer chemotherapy presents notable drug side effects due to non-selective action of the chemotherapeutics to normal cells. Nanoparticles decorated with receptor-specific ligands on the surface have shown an important role in improving
Externí odkaz:
https://doaj.org/article/409e1ebf894f4702a950bd4f7fd7513b
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 10, Pp 3060-3091 (2021)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation and destruction of the lung air-blood barrier, leading to irreversible and substantial respiratory function damage. Patients with coronavirus disease 2019 (COVID-1
Autor:
Kenth Gustafsson, Rana Khalife, Konstantin Pildish, Rupali Dabas, Sofia Esteban Serna, Vladimir Kalinovskiy, Noelle Colant, Matas Deveikis, Alexander Van de Steen, Saverio Charalambous, Hasan Mustafa Khan, Stefanie Frank, Clare M. Robinson, Diana A. Catana
Publikováno v:
Synthetic and Systems Biotechnology, Vol 6, Iss 3, Pp 231-241 (2021)
Synthetic and Systems Biotechnology
Synthetic and Systems Biotechnology
The development of Drug Delivery Systems (DDS) has led to increasingly efficient therapies for the treatment and detection of various diseases. DDS use a range of nanoscale delivery platforms produced from polymeric of inorganic materials, such as mi
Autor:
Liang Han, Chen Jiang
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2306-2325 (2021)
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica. B
Blood–brain barrier (BBB) strictly controls matter exchange between blood and brain, and severely limits brain penetration of systemically administered drugs, resulting in ineffective drug therapy of brain diseases. However, during the onset and pr
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 12, Iss 1, Pp 92-106 (2022)
Acta Pharmaceutica Sinica B, Vol 12, Iss 1, Pp 92-106 (2022)
Nanoparticulate drug delivery systems (Nano-DDSs) have emerged as possible solution to the obstacles of anticancer drug delivery. However, the clinical outcomes and translation are restricted by several drawbacks, such as low drug loading, premature
Publikováno v:
Bioactive Materials
Bioactive Materials, Vol 6, Iss 7, Pp 1973-1987 (2021)
Bioactive Materials, Vol 6, Iss 7, Pp 1973-1987 (2021)
The tumor development and metastasis are closely related to the structure and function of the tumor microenvironment (TME). Recently, TME modulation strategies have attracted much attention in cancer immunotherapy. Despite the preliminary success of
Autor:
Huihui Zou, Zheng Wei, Chuanhui Song, Yu Cai, Sheng Chen, Gongyuan Liu, Wei Han, Jianchuan Ran, Xiteng Yin, Yufeng Wang, Chuanchao Tang, Guorong Zhang
Publikováno v:
Bioactive Materials, Vol 6, Iss 7, Pp 2144-2157 (2021)
Bioactive Materials
Bioactive Materials
Here, evodiamine (EVO) and the photosensitizer indocyanine green (ICG) were integrated into a liposomal nanoplatform for noninvasive diagnostic imaging and combinatorial therapy against oral squamous cell carcinoma (OSCC). EVO, as an active component
Publikováno v:
Advanced Drug Delivery Reviews
Graphical abstract
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Even given recent advances in nanomedicine development of breast cancer treatment in recent years and promising results in pre-clinical models, cancer nanomedicines often fail at the clinical trial stage. Limitations of conven
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2172-2196 (2021)
Acta Pharmaceutica Sinica B, Vol 11, Iss 8, Pp 2172-2196 (2021)
Immunotherapy is a rapidly developing area of cancer treatment due to its higher specificity and potential for greater efficacy than traditional therapies. Immune cell modulation through the administration of drugs, proteins, and cells can enhance an
Autor:
Shijun Zhang, Zhuomao Mo, Wen Ma, Ling Yu, Zhenjie Wang, Binhua Zou, Rui Sun, Yuanyuan Yang, Zhiqiang Yu, Meng Yu
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 11, Iss 7, Pp 2004-2015 (2021)
Acta Pharmaceutica Sinica B, Vol 11, Iss 7, Pp 2004-2015 (2021)
Hepatocellular carcinoma (HCC) has been known as the second common leading cancer worldwide, as it responds poorly to both chemotherapy and medication. Triptolide (TP), a diterpenoid triepoxide, is a promising treatment agent for its effective antica